Rome, Italy

Paola Sinibaldi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paola Sinibaldi. Retrieved from https://idiyas.com/inventor/paola-sinibaldi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paola Sinibaldi: Innovator in Cancer Immunotherapy

Introduction

Paola Sinibaldi is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of cancer immunotherapy, particularly through her innovative research on immunogenic peptides. Her work aims to enhance the immune response against various cancer types, showcasing her dedication to advancing medical science.

Latest Patents

Paola Sinibaldi holds a patent for "Anti tumoral immunogenic peptides and vaccine thereof." This invention relates to novel, Frizzled-like, immunogenic peptides that are useful for stimulating an immune response against various cancer types, particularly colon rectal carcinoma. This patent highlights her commitment to developing effective cancer treatments.

Career Highlights

Throughout her career, Paola has focused on groundbreaking research in immunology and cancer therapy. Her innovative approach has positioned her as a key figure in the scientific community, contributing to the understanding of how the immune system can be harnessed to fight cancer.

Collaborations

Paola has collaborated with notable professionals in her field, including Vito M. Fazio and Guido Rasi. These partnerships have allowed her to expand her research and contribute to significant advancements in cancer treatment.

Conclusion

Paola Sinibaldi's work in developing immunogenic peptides represents a vital step forward in cancer immunotherapy. Her dedication to innovation and collaboration continues to inspire advancements in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…